A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 1,025,868 shares of JAZZ stock, worth $122 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares
1,025,868
Previous 1,165,568 11.99%
Holding current value
$122 Million
Previous $140 Million 21.99%
% of portfolio
0.19%
Previous 0.22%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$103.94 - $118.98 $14.5 Million - $16.6 Million
-139,700 Reduced 11.99%
1,025,868 $109 Million
Q1 2024

May 13, 2024

SELL
$115.19 - $132.77 $7.6 Million - $8.76 Million
-66,006 Reduced 5.36%
1,165,568 $140 Million
Q4 2023

Feb 13, 2024

SELL
$114.26 - $136.0 $8.69 Million - $10.3 Million
-76,041 Reduced 5.82%
1,231,574 $151 Million
Q3 2023

Nov 14, 2023

BUY
$122.0 - $145.31 $2.14 Million - $2.54 Million
17,506 Added 1.36%
1,307,615 $169 Million
Q2 2023

Aug 11, 2023

BUY
$122.5 - $147.16 $4.35 Million - $5.22 Million
35,500 Added 2.83%
1,290,109 $160 Million
Q1 2023

May 12, 2023

SELL
$133.98 - $160.47 $4.74 Million - $5.68 Million
-35,406 Reduced 2.74%
1,254,609 $184 Million
Q4 2022

Feb 13, 2023

SELL
$129.72 - $159.85 $1.1 Million - $1.36 Million
-8,494 Reduced 0.65%
1,290,015 $206 Million
Q3 2022

Nov 14, 2022

SELL
$126.59 - $161.18 $16.2 Million - $20.6 Million
-127,600 Reduced 8.95%
1,298,509 $173 Million
Q2 2022

Aug 12, 2022

SELL
$141.59 - $168.66 $12.9 Million - $15.4 Million
-91,200 Reduced 6.01%
1,426,109 $222 Million
Q1 2022

May 13, 2022

SELL
$129.64 - $160.7 $23.8 Million - $29.4 Million
-183,200 Reduced 10.77%
1,517,309 $236 Million
Q4 2021

Feb 11, 2022

SELL
$119.87 - $145.67 $35.8 Million - $43.5 Million
-298,500 Reduced 14.93%
1,700,509 $217 Million
Q3 2021

Nov 12, 2021

SELL
$128.64 - $184.79 $40.9 Million - $58.8 Million
-318,231 Reduced 13.73%
1,999,009 $260 Million
Q2 2021

Aug 13, 2021

SELL
$160.2 - $186.42 $55.3 Million - $64.4 Million
-345,410 Reduced 12.97%
2,317,240 $412 Million
Q1 2021

May 13, 2021

SELL
$150.19 - $173.5 $65.5 Million - $75.7 Million
-436,400 Reduced 14.08%
2,662,650 $438 Million
Q4 2020

Feb 10, 2021

SELL
$140.71 - $165.05 $33.2 Million - $38.9 Million
-235,900 Reduced 7.07%
3,099,050 $511 Million
Q3 2020

Nov 13, 2020

SELL
$105.46 - $144.13 $15.1 Million - $20.6 Million
-143,263 Reduced 4.12%
3,334,950 $476 Million
Q2 2020

Aug 13, 2020

BUY
$95.68 - $121.88 $3.79 Million - $4.83 Million
39,663 Added 1.15%
3,478,213 $384 Million
Q1 2020

May 14, 2020

SELL
$87.74 - $152.74 $9.72 Million - $16.9 Million
-110,821 Reduced 3.12%
3,438,550 $343 Million
Q4 2019

Feb 13, 2020

BUY
$117.65 - $153.73 $50.8 Million - $66.4 Million
431,670 Added 13.85%
3,549,371 $530 Million
Q3 2019

Nov 13, 2019

BUY
$125.18 - $143.24 $70.3 Million - $80.5 Million
561,900 Added 21.99%
3,117,701 $400 Million
Q2 2019

Aug 12, 2019

BUY
$125.55 - $144.48 $70.6 Million - $81.3 Million
562,700 Added 28.23%
2,555,801 $364 Million
Q1 2019

May 14, 2019

BUY
$121.81 - $142.95 $103 Million - $120 Million
842,900 Added 73.28%
1,993,101 $285 Million
Q4 2018

Feb 13, 2019

BUY
$115.94 - $166.74 $133 Million - $192 Million
1,150,201 New
1,150,201 $143 Million

Others Institutions Holding JAZZ

About Jazz Pharmaceuticals plc


  • Ticker JAZZ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,680,700
  • Market Cap $7.46B
  • Description
  • Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...
More about JAZZ
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.